A paper by Kei Sato’s group (Division of Systems Immunology) was published in The LANCET Infectious Diseases.
2023年9月11日
A paper by Kei Sato’s group (Division of Systems Immunology) was published in The LANCET Infectious Diseases.
Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5.
Kaku Y, Kosugi Y, Uriu K, Ito J, Hinay AA Jr, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K.
Lancet Infect Dis. 2023 Oct;23(10):e395-e396. doi: 10.1016/S1473-3099(23)00553-4.